Search This Blog:    HIV   MPOX

DeutschEspañolFrançaisItaliano

 


Zim embarks on new HIV study

Zim embarks on new HIV study
In this latest study known as AMP (Antibody Mediated Prevention), scientists have manufactured an antibody called VRC01, which will be infused in humans participating in the study through intravenous (IV) fluid (popularly known as a drip) once, after every eight weeks for two years.
In an interview during the AMP study update meeting, which took place recently in Cape Town, South Africa, protocol co-chairperson Dr Nyaradzo Mgodi, said this concept was similar to how vaccines for polio or chicken pox were developed.

Top stories of the last 30 days